About Linical
Linical is a publicly listed company based in Osaka (Japan) founded in 2005. Full-service CRO operations are conducted across more than 20 countries. Linical has completed 1 acquisition, including Accelovance. Its chief executive, as recorded, is Keigo Tsujimoto. Its website linical.com draws about 13 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.
Company details
Linical is a full-service CRO, headquartered in Japan and operations in 20 countries which includes all major markets in the Asia-Pacific, North American and European regions. Their service portfolio includes project management, clinical monitoring, data management, statistical analysis, medical writing, pharmacovigilance, regulatory affairs, medical management. They offer their clinical trial services in a wide range of therapeutic areas and claim to have expertise in oncology, CNS, immunology, respiratory, allergy, endocrinology and GI disorders.
- Headquarters Osaka, Japan
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website linical.com
- Social LinkedIn X Facebook
- Legal Name Linical Co., Ltd.
- Annual Revenue$54.36 M (USD)-16.97as on Mar 31, 2026
- Net Profit-$20.88 M (USD)-517.61as on Mar 31, 2026
- EBITDA-$9.66 M (USD)-3209.42as on Mar 31, 2026
- Investments & Acquisitions
People of Linical
45 people are tracked at Linical (23 in leadership, 22 in team).
| Name | Role | Group |
|---|---|---|
Keigo Tsujimoto | Chairman & CEO | Leadership |
Rebecca Lamborn | Chief Financial Officer, Western Region | Leadership |
Clareece West | President And CCO | Leadership |
Tracy Goeken | Chief Medical Officer | Leadership |
Joerg Clef | Chief Financial Officer (cfo) Europe | Leadership |
Samantha Walsh | Senior Director, Business Development | Leadership |
Angel Perez Romero | Director Clinical Operations | Leadership |
Ali Cundari | Senior Director, Marketing And Corporate Communications | Leadership |
Jun Kawai | Executive Vice President | Leadership |
Akihiro Takahashi | Executive Vice President, Chief Financial Officer (cfo) | Leadership |
Masaya Miyazaki | Executive Vice President, Linical Japan | Leadership |
Shiori Yamaguchi | Executive Director | Leadership |
Kazuhiro Hatano | President & CEO | Leadership |
Dr. Anthony Harris | Director Of Business Devleopment | Leadership |
Marisol Ribes | VP HR Linical US And Europe | Leadership |
Jonathan White | Senior Director Of Biostatistics | Leadership |
Jeffry Chen | Director Of Project Management | Leadership |
Suzanne Mathias | Senior Director Clinical Monitoring | Leadership |
Summer Nettleman | Director, Contract Services And Legal Affairs | Leadership |
Kian C. Su | Associate Director | Leadership |
25 more people are available in the full profile.
Complete people profiles for Linical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Linical
Linical is a publicly listed company on the TSE with ticker symbol 2183 in Japan, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Oct 2008
- Listed onTSE: 2183
- Listed entityLinical Co., Ltd.
- Exchange sectorCommercial services
- ISINJP3974530002
- Share price200.00 JPY · 2026-10-14
- Market capitalisation4,517,287,064.00 JPY
- EPS (diluted, trailing year)-167.75 JPY
- Dividend yield4%
- Volume (last session)33,700
Financials of Linical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 8.67B JPY | -3.33B JPY | -1.54B JPY |
| 2024 | 10.44B JPY | -539.1M JPY | -46.5M JPY |
| 2023 | 12.31B JPY | 338.3M JPY | 1.25B JPY |
| 2022 | 12.52B JPY | 1.00B JPY | 1.76B JPY |
| 2021 | 11.56B JPY | 790.5M JPY | 1.54B JPY |
Detailed financial statements for Linical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Linical
Linical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Accelovance.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CRO specializing in Phase I-IV programs of Vaccines, Early Phase Oncology, and General medicine | accelovance.com | Rockville, United States | 2005 | Mar 2018 | •••• |
Complete acquisition details for Linical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Linical
3 dated milestones of Linical across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Linical is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Accelovance.
Web traffic of Linical
The website of Linical (linical.com) receives about 12.8K visits a month and ranks #2,084,675 among all websites worldwide, #2,844 in Biotechnology and Pharmaceuticals.
- Monthly visits12.8K
▲ 21.2% vs previous month
- Unique visitors4.8K
per month
- Global rank#2,084,675
among all websites
- Category rank#2,844
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit1.9
- Average visit1 min 13 sec
- DevicesDesktop 42% · Mobile 58%
Websites whose visitors overlap most with Linical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| qbdgroup.com | 100% | #976,787 | View details | ||
linical.sharepoint.com | linical.sharepoint.com | 92% | – | ||
cra-bank.com | cra-bank.com | 88% | #1,593,651 | – | |
imedidata.com | imedidata.com | 83% | #36,142 | – | |
diaglobal.org | diaglobal.org | 81% | #445,407 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Linical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Linical
Complete news archive for Linical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linical
Linical was founded in 2005.
Linical is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Keigo Tsujimoto is the CEO of Linical, as recorded in our data.
Annual revenue of Linical is $54.36M as on Mar 31, 2026.
Linical is a full-service CRO, headquartered in Japan and operations in 20 countries which includes all major markets in the Asia-Pacific, North American and European regions. Their service portfolio includes project management, clinical monitoring, data management, statistical analysis, medical writing, pharmacovigilance, regulatory affairs, medical management. They offer their clinical trial services in a wide range of therapeutic areas and claim to have expertise in oncology, CNS, immunology, respiratory, allergy, endocrinology and GI disorders.
Yes, Linical is publicly traded on TSE under the ticker symbol 2183.
Linical has made 1 acquisition, including Accelovance.